Transcriptomics
7
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Molecular Profiling of MRI-PSMA PET Discordance in Prostate Cancer
Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)
Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue
Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data
Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis
A Multi-omics Study of Epithelial Ovarian Cancer
A Multi-omics Study of Adenomyosis